OBJECTIVE: Clarifying age-specific female breast cancer risks and interactions may provide important etiologic clues. METHOD: Using a population-based case-control study in Poland (2000-2003) of 2,386 incident breast cancer cases and 2,502 control subjects aged 25-74 years, we estimated age-specific breast cancer incidence rates according to risk factors. RESULTS: Breast cancer risks were elevated among women with positive family history (FH), younger age at menarche, older age at first full-term birth, nulliparity, exogenous hormonal usage, and reduced physical activity (PA). Notwithstanding overall risks, we observed statistically significant quantitative (non-crossover) and qualitative (crossover) age interactions for all risk factors except for FH and PA. For example, nulliparity compared to parity reduced breast cancer risk among women ages 25-39 years then rates crossed or reversed, after which nulliparity increased relative risks among women ages 40-74 years. CONCLUSION: Though quantitative age interactions could be expected, qualitative interactions were somewhat counterintuitive. If confirmed in other populations, qualitative interactions for a continuous covariate such as age will be difficult to reconcile in a sequential (multistep or monolithic) 'stochastic' breast cancer model. Alternatively, the reversal of relative risks among younger and older women suggests subgroup heterogeneity with different etiologic mechanisms for early-onset and late-onset breast cancer types.
OBJECTIVE: Clarifying age-specific female breast cancer risks and interactions may provide important etiologic clues. METHOD: Using a population-based case-control study in Poland (2000-2003) of 2,386 incident breast cancer cases and 2,502 control subjects aged 25-74 years, we estimated age-specific breast cancer incidence rates according to risk factors. RESULTS:Breast cancer risks were elevated among women with positive family history (FH), younger age at menarche, older age at first full-term birth, nulliparity, exogenous hormonal usage, and reduced physical activity (PA). Notwithstanding overall risks, we observed statistically significant quantitative (non-crossover) and qualitative (crossover) age interactions for all risk factors except for FH and PA. For example, nulliparity compared to parity reduced breast cancer risk among women ages 25-39 years then rates crossed or reversed, after which nulliparity increased relative risks among women ages 40-74 years. CONCLUSION: Though quantitative age interactions could be expected, qualitative interactions were somewhat counterintuitive. If confirmed in other populations, qualitative interactions for a continuous covariate such as age will be difficult to reconcile in a sequential (multistep or monolithic) 'stochastic' breast cancer model. Alternatively, the reversal of relative risks among younger and older women suggests subgroup heterogeneity with different etiologic mechanisms for early-onset and late-onset breast cancer types.
Authors: Mark E Sherman; Jonine D Figueroa; Jill E Henry; Susan E Clare; Connie Rufenbarger; Anna Maria Storniolo Journal: Cancer Prev Res (Phila) Date: 2012-02-17
Authors: Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein Journal: Breast Cancer Res Treat Date: 2011-06-11 Impact factor: 4.872
Authors: Min Shi; Katie M O'Brien; Dale P Sandler; Jack A Taylor; Dmitri V Zaykin; Clarice R Weinberg Journal: Breast Cancer Res Treat Date: 2016-11-15 Impact factor: 4.872
Authors: William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman Journal: J Natl Cancer Inst Date: 2014-08-12 Impact factor: 13.506
Authors: Katie M O'Brien; Alexandra J White; Brian P Jackson; Margaret R Karagas; Dale P Sandler; Clarice R Weinberg Journal: Am J Epidemiol Date: 2019-04-01 Impact factor: 4.897
Authors: Katie M O'Brien; Alexandra J White; Brian P Jackson; Margaret R Karagas; Dale P Sandler; Clarice R Weinberg Journal: Am J Epidemiol Date: 2019-11-01 Impact factor: 4.897
Authors: Jonine D Figueroa; Kathleen C Flanders; Montserrat Garcia-Closas; William F Anderson; Xiaohong R Yang; Rayna K Matsuno; Máire A Duggan; Ruth M Pfeiffer; Akira Ooshima; Robert Cornelison; Gretchen L Gierach; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Lalage M Wakefield; Mark E Sherman Journal: Breast Cancer Res Treat Date: 2009-11-24 Impact factor: 4.872
Authors: Graça M Dores; Rayna K Matsuno; Dennis D Weisenburger; Philip S Rosenberg; William F Anderson Journal: Br J Haematol Date: 2008-05-08 Impact factor: 6.998